Literature DB >> 10714093

Apoptosis in dilated cardiomyopathy.

B K Hong1, H M Kwon, K H Byun, D Kim, E Y Choi, T S Kang, S M Kang, K J Chun, Y Jang, H S Kim, M Kim.   

Abstract

OBJECTIVE: Cardiomyopathy, a popular diagnosis that always obscures more than it reveals, nevertheless has several characteristic histological features. These prominently include widespread focal myocardial fibrosis and associated hypertrophy of surviving cardiac myocyte. In fact, focal noninflammatory degeneration (not necrosis) has been demonstrated as a feature of many forms of cardiac hypertrophy. We hypothesized that this loss of myocardial cells in dilated cardiomyopathy (DCMP) may result from cell death by apoptosis.
METHODS: Endomyocardial biopsy specimens from the right ventricles of six patients who suffered from DCMP were studied, and myocardial specimens from two persons who died in motor vehicle accidents were used as negative controls. For identification of apoptosis, immunohistochemistry with terminal deoxynucleotidyl transferase (TdT)-mediated dUTP-biotin nick end-labeling was performed. In addition, apoptosis was confirmed morphologically by confocal laser scanning microscopy with propidium iodide.
RESULTS: Apoptosis, that was represented by an apoptotic index ranging from 19.8 to 25.4%, could be extensively seen in myocytes and also rarely in non-myocytes of interstitium and vascular endothelium. Morphologically, there were a lot of nuclei with clumps of condensed chromatin, suggestive of apoptosis.
CONCLUSION: The present study demonstrated that myocyte loss in DCMP might be mainly due to the apoptosis of myocytes and interstitial cells, rather than inflammation or cell necrosis.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10714093      PMCID: PMC4531747          DOI: 10.3904/kjim.2000.15.1.56

Source DB:  PubMed          Journal:  Korean J Intern Med        ISSN: 1226-3303            Impact factor:   2.884


  56 in total

Review 1.  Age and the cardiovascular system.

Authors:  J Y Wei
Journal:  N Engl J Med       Date:  1992-12-10       Impact factor: 91.245

2.  Programmed cell death and expression of the protooncogene bcl-2 in myocytes during postnatal maturation of the heart.

Authors:  J Kajstura; M Mansukhani; W Cheng; K Reiss; S Krajewski; J C Reed; F Quaini; E H Sonnenblick; P Anversa
Journal:  Exp Cell Res       Date:  1995-07       Impact factor: 3.905

Review 3.  Molecular signalling mechanisms controlling growth and function of cardiac fibroblasts.

Authors:  G W Booz; K M Baker
Journal:  Cardiovasc Res       Date:  1995-10       Impact factor: 10.787

Review 4.  Cell death: the significance of apoptosis.

Authors:  A H Wyllie; J F Kerr; A R Currie
Journal:  Int Rev Cytol       Date:  1980

5.  Characteristics and prognostic implications of myosin missense mutations in familial hypertrophic cardiomyopathy.

Authors:  H Watkins; A Rosenzweig; D S Hwang; T Levi; W McKenna; C E Seidman; J G Seidman
Journal:  N Engl J Med       Date:  1992-04-23       Impact factor: 91.245

Review 6.  Patterns of cell death.

Authors:  N I Walker; B V Harmon; G C Gobé; J F Kerr
Journal:  Methods Achiev Exp Pathol       Date:  1988

Review 7.  Apoptosis. Its significance in cancer and cancer therapy.

Authors:  J F Kerr; C M Winterford; B V Harmon
Journal:  Cancer       Date:  1994-04-15       Impact factor: 6.860

8.  Myocyte nuclear mitotic division and programmed myocyte cell death characterize the cardiac myopathy induced by rapid ventricular pacing in dogs.

Authors:  Y Liu; E Cigola; W Cheng; J Kajstura; G Olivetti; T H Hintze; P Anversa
Journal:  Lab Invest       Date:  1995-12       Impact factor: 5.662

9.  DNA fragmentation of human infarcted myocardial cells demonstrated by the nick end labeling method and DNA agarose gel electrophoresis.

Authors:  G Itoh; J Tamura; M Suzuki; Y Suzuki; H Ikeda; M Koike; M Nomura; T Jie; K Ito
Journal:  Am J Pathol       Date:  1995-06       Impact factor: 4.307

10.  Impairment of the myocardial ultrastructure and changes of the cytoskeleton in dilated cardiomyopathy.

Authors:  J Schaper; R Froede; S Hein; A Buck; H Hashizume; B Speiser; A Friedl; N Bleese
Journal:  Circulation       Date:  1991-02       Impact factor: 29.690

View more
  8 in total

1.  Fat streak in the middle layer of the left ventricular myocardium in a patient with dilated cardiomyopathy: findings of multidetector CT and MR imaging.

Authors:  Song Soo Kim; Sung Min Ko; Meong Gun Song
Journal:  Int J Cardiovasc Imaging       Date:  2011-04-03       Impact factor: 2.357

Review 2.  A Comprehensive Outlook on Dilated Cardiomyopathy (DCM): State-Of-The-Art Developments with Special Emphasis on OMICS-Based Approaches.

Authors:  Vivek Sarohi; Shriya Srivastava; Trayambak Basak
Journal:  J Cardiovasc Dev Dis       Date:  2022-06-01

Review 3.  A synopsis of research in cardiac apoptosis and its application to congestive heart failure.

Authors:  Ali Khoynezhad; Ziba Jalali; Anthony J Tortolani
Journal:  Tex Heart Inst J       Date:  2007

4.  Histamine 2 receptor antagonism elicits protection against doxorubicin-induced cardiotoxicity in rodent model.

Authors:  Sundar Kumar Kondru; Ajay Godwin Potnuri; Lingesh Allakonda; Prasad Konduri
Journal:  Mol Cell Biochem       Date:  2017-09-08       Impact factor: 3.396

5.  The Chinese Herb Yi-Qi-Huo-Xue Protects Cardiomyocyte Function in Diabetic Cardiomyopathy.

Authors:  Xiangsheng Wang; Jing Huang; Shengyi Wang; Qing Ni
Journal:  Evid Based Complement Alternat Med       Date:  2018-05-06       Impact factor: 2.629

6.  Inhibition of myocardial cathepsin-L release during reperfusion following myocardial infarction improves cardiac function and reduces infarct size.

Authors:  Weihong He; Charlotte S McCarroll; Katrin Nather; Kristopher Ford; Kenneth Mangion; Alexandra Riddell; Dylan O'Toole; Ali Zaeri; David Corcoran; David Carrick; Mathew M Y Lee; Margaret McEntegart; Andrew Davie; Richard Good; Mitchell M Lindsay; Hany Eteiba; Paul Rocchiccioli; Stuart Watkins; Stuart Hood; Aadil Shaukat; Lisa McArthur; Elspeth B Elliott; John McClure; Catherine Hawksby; Tamara Martin; Mark C Petrie; Keith G Oldroyd; Godfrey L Smith; Keith M Channon; Colin Berry; Stuart A Nicklin; Christopher M Loughrey
Journal:  Cardiovasc Res       Date:  2022-05-06       Impact factor: 13.081

Review 7.  Arrhythmogenic Cardiomyopathy: Exercise Pitfalls, Role of Connexin-43, and Moving beyond Antiarrhythmics.

Authors:  Isabella Leite Coscarella; Maicon Landim-Vieira; José Renato Pinto; Stephen P Chelko
Journal:  Int J Mol Sci       Date:  2022-08-06       Impact factor: 6.208

8.  Alcohol and Apoptosis: Friends or Foes?

Authors:  Ana Rodriguez; Karan Chawla; Nsini A Umoh; Valerie M Cousins; Assama Ketegou; Madhumati G Reddy; Mustafa AlRubaiee; Georges E Haddad; Mark W Burke
Journal:  Biomolecules       Date:  2015-11-19
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.